Teva Sues Glenmark In Latest Suit Over Generic Coreg
Teva Pharmaceuticals Industries Ltd. has filed a lawsuit accusing rival generic-drug maker Glenmark Pharmaceuticals Ltd. of infringing patents for the preparation of a generic version of Coreg, GlaxoSmithKline PLC's congestive heart...To view the full article, register now.
Already a subscriber? Click here to view full article